Skip to main content
Premium Trial:

Request an Annual Quote

Researchers Finding Mutations in Second AML Genome

DENVER (GenomeWeb News) – Researchers are wrapping up their analysis of the second acute myeloid leukemia genome, Elaine Mardis, co-director of Washington University's Genome Sequencing Center, told attendees at the American Association for Cancer Research meeting in Denver yesterday.

Researchers started using targeted re-sequencing to assess the genetics of AML, a blood-forming cell cancer, in 2002. While that approach turned up a handful of genes frequently mutated in AML, it did not provide a complete picture of somatic mutations, structural changes, and other genetic alterations associated with the cancer, Mardis explained during her presentation.

In an effort to obtain a more complete view of AML genetics, she and her colleagues have been assessing entire AML genomes — an approach that provides an unbiased view of AML genetics. Last November, the team reported in Nature that they had sequenced the complete tumor and normal genome from the same AML patient, a woman with cytogenetically normal AML. The team identified eight somatic mutations and two indels in the AML1 genome.

Now, Mardis said the researchers have just finished analyzing the second AML genome. For that study, the researchers sequenced normal and tumor tissue from a Caucasian man with de novo M1 AML using the Illumina Genome Analyzer II platform.

Mardis touted the value of paired end reads for deciphering information on everything from single base mutations to structure variations and copy number changes, all using the same dataset.

Although she noted that the sequencing throughput was lower when the team sequenced the first AML genomes, Mardis said the current sequencing output is roughly 18 gigabases per instrument run. Read length has also improved and is currently about 75 base pairs, she added.

Their work uncovered dozens of somatic mutations as well as a couple of somatic indels in the AML2 genome. Mardis did not disclose details of the genes affected, noting the team plans to submit the work for publication.

Along with DNA sequencing, the team is working on RNA sequencing studies aimed at unraveling the AML2 transcriptome. In addition, Mardis said the researchers are currently sequencing a third AML genome and have selected several patients with AML M1 and M3 subtypes for additional genome studies.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.